FANGZHOU JIANKE (06086) has been included in the list of stocks eligible for Southbound trading under the Shanghai-Hong Kong Stock Connect.
Ark Health Inc. (06086) announced that, according to the Shanghai Stock Exchange's notice on March 7, 2025 regarding the Shanghai-Hong Kong Stock Connect...
FANGZHOU JIANKE (06086) announced that, according to the notice from the Shanghai Stock Exchange on the adjustment of the Stock Connect southbound securities under the Shanghai-Hong Kong Stock Connect on March 7, 2025, the company has been included in the list of southbound securities under the Stock Connect southbound of the Shanghai-Hong Kong Stock Connect, which will officially take effect on March 10, 2025.
The board of directors believes that the company's inclusion in the list of southbound securities under the Stock Connect southbound of the Shanghai-Hong Kong Stock Connect will help enhance the company's recognition in the capital market and enable the company to reach a broader group of investors in the mainland. At the same time, it will create opportunities for the company's customers, partners, and investors to participate in the company's innovative internet healthcare and related artificial intelligence applications solutions.
Related Articles

Sinolink: Escalation of US-Iran conflict reverses "weak US dollar" narrative, strong assets may help reverse market decline and indicate a bottom.

Huachuang Securities: Under the impact of high oil prices in this round, the middle and upper reaches of the profit margin may have more resilience.

Hua Chuang Securities' Zhang Yu: High oil prices bring "clearing out," China's midstream market share may "rise"
Sinolink: Escalation of US-Iran conflict reverses "weak US dollar" narrative, strong assets may help reverse market decline and indicate a bottom.

Huachuang Securities: Under the impact of high oil prices in this round, the middle and upper reaches of the profit margin may have more resilience.

Hua Chuang Securities' Zhang Yu: High oil prices bring "clearing out," China's midstream market share may "rise"

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


